TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Assets | ₹61 Cr | ₹33 Cr | ₹12 Cr | ₹2.10 Cr |
What is the latest Total Non-Current Assets ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹2.10 Cr |
How is Total Non-Current Assets of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 83.70 | |
| Mar2024 | ₹33 Cr | 170.90 | |
| Mar2023 | ₹12 Cr | 479.86 | |
| Mar2022 | ₹2.10 Cr | - | |
Compare Total Non-Current Assets of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹490.7 Cr | 5.8% | 5% | 44.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 5.8% |
5% |
44.6% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses